Pages that link to "Q70298320"
Jump to navigation
Jump to search
The following pages link to Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension (Q70298320):
Displaying 13 items.
- Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy (Q28372859) (← links)
- Hyperlipidemia (Q33986367) (← links)
- Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo (Q36755124) (← links)
- Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease (Q38658263) (← links)
- The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs (Q39460803) (← links)
- The effects of beta-adrenergic blocking agents on blood lipid levels (Q39464499) (← links)
- Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders (Q39478484) (← links)
- Serum lipoproteins during treatment with antihypertensive drugs (Q39513754) (← links)
- Alpha- and beta-blockade in angina pectoris. (Q40096624) (← links)
- Antihypertensive drugs: issues beyond blood pressure control (Q40621879) (← links)
- Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients (Q51627282) (← links)
- Selection of antihypertensive therapy (Q68887795) (← links)
- Risk factors in the management of the unique hypertensive patient (Q69030017) (← links)